SIRT1 and metabolic disease: Since NAD+-dependent SIRT1 activity is essential for a normal metabolic function [20], treatments that target the cellular NAD+-SIRT1 axis represent a potential preventive/therapeutic intervention strategy for obesity- and aging-related metabolic disorders (Figure 2).